Profile for Japan Patent: 6073202
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for Japan Patent: 6073202
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
⤷ Sign Up | Feb 12, 2027 | Biocryst | RAPIVAB | peramivir |
⤷ Sign Up | May 7, 2027 | Biocryst | RAPIVAB | peramivir |
>US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |